Carlos Gomez-Roca
16PUBLICATIONS
239CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Apr 09, 2026
Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.Jose Luis Perez-Gracia, Begoña Mellado, Aaron Richard Hansen
|Feb 26, 2026
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca
|Jan 21, 2026
Innovative Research Organization to Facilitate Clinical Trials Implementation in the Era of Molecular Oncology: The Spiderweb Model of the Oncodistinct Network.Simon Nannini, Anthony Goncalves, Carlos Gomez-Roca
|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.Kevin J Harrington, Stephane Champiat, Joshua D Brody
|Apr 08, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.Olivier Trédan, Damien Pouessel, Nicolas Penel
|Dec 13, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.Jason J Luke, Karen Gelmon, Lillian L Siu
Pageof 3
Frequent Collaborators
3 joint publications
Jehad Charo
3 joint publications
Stephane Champiat
2 joint publications
Aaron Richard Hansen
2 joint publications
Debbie Robbrecht
2 joint publications
Caroline Ardeshir
2 joint publications
Antoine Italiano
2 joint publications
Neeltje Steeghs
2 joint publications
David Dejardin
2 joint publications
Christophe Boetsch
2 joint publications
Stefan Evers
